• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

递呈编码:用于脱氧核糖核酸和核糖核酸干扰治疗的多聚物载体。

Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies.

机构信息

Department of Materials Engineering, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.

出版信息

Endocrinology. 2010 Feb;151(2):466-73. doi: 10.1210/en.2009-1045. Epub 2009 Dec 23.

DOI:10.1210/en.2009-1045
PMID:20032060
Abstract

Nucleic acid-based therapies offer great potential for treatment of a variety of diseases including cancer by modulating protein expression with DNA or small interfering RNA. However, realization of their full therapeutic potential is currently limited due to an inability to reach the target site in an active form. Identification of delivery barriers such as stability in circulation, resistance to degradation and entrapment in subcellular vesicles has led to development of sophisticated multifunctional synthetic polymers for forming ionic complexes with nucleic acids and also providing performance-enhancing features. The most promising designs comprise features to help increase stability in circulation and also contain functionality to aid in endosome escape of nucleic acid cargo after cellular internalization.

摘要

核酸治疗为治疗多种疾病提供了巨大的潜力,包括通过调节 DNA 或小干扰 RNA 表达来治疗癌症。然而,由于无法以活性形式到达靶位,它们的全部治疗潜力目前受到限制。识别递药障碍,如在循环中的稳定性、抵抗降解和被困在亚细胞囊泡中,导致了复杂的多功能合成聚合物的发展,这些聚合物可以与核酸形成离子复合物,并提供增强性能的特性。最有前途的设计包括帮助增加循环稳定性的特性,并且还包含有助于核酸货物在细胞内化后逃离内涵体的功能。

相似文献

1
Delivering the code: polyplex carriers for deoxyribonucleic acid and ribonucleic acid interference therapies.递呈编码:用于脱氧核糖核酸和核糖核酸干扰治疗的多聚物载体。
Endocrinology. 2010 Feb;151(2):466-73. doi: 10.1210/en.2009-1045. Epub 2009 Dec 23.
2
Peptide vectors for the nonviral delivery of nucleic acids.肽载体用于非病毒递送核酸。
Acc Chem Res. 2012 Jul 17;45(7):1048-56. doi: 10.1021/ar2002304. Epub 2012 Mar 28.
3
Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.用于耐药肿瘤核酸治疗的纳米递送系统
Mol Pharm. 2014 Aug 4;11(8):2511-26. doi: 10.1021/mp500024p. Epub 2014 Apr 1.
4
[Research progress in co-delivery of gene and chemotherapy drugs with nanocarriers for cancer therapy].[纳米载体用于癌症治疗的基因与化疗药物共递送研究进展]
Yao Xue Xue Bao. 2013 Jul;48(7):1091-8.
5
Development of plasmid-lipid complexes for direct intratumoral injection.用于直接瘤内注射的质粒-脂质复合物的研发。
Methods Mol Biol. 2014;1139:467-76. doi: 10.1007/978-1-4939-0345-0_36.
6
A review of the current status of siRNA nanomedicines in the treatment of cancer.一种用于癌症治疗的 siRNA 纳米药物的现状综述。
Biomaterials. 2013 Sep;34(27):6429-43. doi: 10.1016/j.biomaterials.2013.04.060. Epub 2013 May 30.
7
Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.反义寡脱氧核苷酸、反基因寡脱氧核苷酸及小干扰RNA对基因表达的调控
Expert Opin Drug Deliv. 2005 Jan;2(1):3-28. doi: 10.1517/17425247.2.1.3.
8
Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.RNA 干扰介导的基因沉默的治疗潜力:原理、挑战与新策略。
Gene. 2014 Apr 1;538(2):217-27. doi: 10.1016/j.gene.2013.12.019. Epub 2014 Jan 7.
9
Histidine-lysine peptides as carriers of nucleic acids.组氨酸-赖氨酸肽作为核酸载体
Drug News Perspect. 2007 Mar;20(2):77-86. doi: 10.1358/dnp.2007.20.2.1083026.
10
Bioresponsive polymer-based nucleic acid carriers.基于生物响应性聚合物的核酸载体
Adv Genet. 2014;88:289-323. doi: 10.1016/B978-0-12-800148-6.00010-9.

引用本文的文献

1
Regiocontrol of the Bulk Polymerization of Lysine Ethyl Ester by the Selection of Suitable Immobilized Enzyme Catalysts.通过选择合适的固定化酶催化剂对赖氨酸乙酯的本体聚合进行区域控制。
Biomacromolecules. 2024 Aug 12;25(8):5110-5120. doi: 10.1021/acs.biomac.4c00497. Epub 2024 Jul 15.
2
Photochemical and biological dual-effects enhance the inhibition of photosensitizers for tumour growth.光化学和生物双重效应增强了光敏剂对肿瘤生长的抑制作用。
Chem Sci. 2024 Apr 25;15(20):7757-7766. doi: 10.1039/d4sc00874j. eCollection 2024 May 22.
3
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery.
纳米药物递送中克服内体/溶酶体屏障的先进策略
Research (Wash D C). 2023 May 24;6:0148. doi: 10.34133/research.0148. eCollection 2023.
4
MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection-Narrative Review.微小 RNA 作为一种诊断工具、治疗靶点和潜在的生物标志物在皮肤恶性黑色素瘤检测中的应用-叙述性综述。
Int J Mol Sci. 2023 Mar 11;24(6):5386. doi: 10.3390/ijms24065386.
5
miRNA therapeutics in precision oncology: a natural premium to nurture.精准肿瘤学中的miRNA疗法:有待培育的天然优势。
Explor Target Antitumor Ther. 2022;3(4):511-532. doi: 10.37349/etat.2022.00098. Epub 2022 Aug 31.
6
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.miRNA 与 SARS-CoV-2 的对话和潜在的抗 COVID-19 疗法。
Life Sci. 2022 Sep 15;305:120761. doi: 10.1016/j.lfs.2022.120761. Epub 2022 Jul 1.
7
The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint.微 RNA 治疗药物发展中的挑战与机遇:多学科视角。
Cells. 2021 Nov 9;10(11):3097. doi: 10.3390/cells10113097.
8
DNA Polyplexes of a Phosphorylcholine-Based Zwitterionic Polymer for Gene Delivery.基于磷酸胆碱的两性离子聚合物的 DNA 多聚物用于基因传递。
Pharm Res. 2020 Aug 28;37(9):176. doi: 10.1007/s11095-020-02899-5.
9
Challenges identifying efficacious miRNA therapeutics for cancer.识别有效的癌症miRNA治疗方法面临的挑战。
Expert Opin Drug Discov. 2020 Sep;15(9):987-992. doi: 10.1080/17460441.2020.1765770. Epub 2020 May 18.
10
Counterion of Chitosan Influences Thermodynamics of Association of siRNA with a Chitosan-Based siRNA Carrier.壳聚糖反离子影响基于壳聚糖的 siRNA 载体与 siRNA 缔合的热力学。
Pharm Res. 2020 Jan 2;37(2):22. doi: 10.1007/s11095-019-2751-z.